These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39319299)

  • 1. A study on the mediating-moderate effect of the types of illicit drugs on mental health in China.
    Zhou B; Tan J; Li W; Yu C
    Front Public Health; 2024; 12():1431854. PubMed ID: 39319299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortalities of methamphetamine, opioid, and ketamine abusers in Shanghai and Wuhan, China.
    Li F; Liu J; Yip PSF; Lu X; Liu S
    Forensic Sci Int; 2020 Jan; 306():110093. PubMed ID: 31816483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in Use/Misuse of Specific Illicit and Prescription Drugs among Sexual Minority Adults in a National Sample.
    Schuler MS; Collins RL; Ramchand R
    Subst Use Misuse; 2022; 57(3):461-471. PubMed ID: 35067155
    [No Abstract]   [Full Text] [Related]  

  • 4. Consumption of common illicit drugs in twenty-one cities in southwest China through wastewater analysis.
    Wang H; Xu B; Yang L; Huo T; Bai D; An Q; Li X
    Sci Total Environ; 2022 Dec; 851(Pt 1):158105. PubMed ID: 35987225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of illicit drug consumption in a population of Hanoi: an estimation using wastewater-based epidemiology.
    Hue TTT; Zheng Q; Anh NTK; Binh VN; Trung NQ; Trang HT; Chinh PQ; Minh LQ; Thai PK
    Sci Total Environ; 2022 Apr; 815():152724. PubMed ID: 34995598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China.
    Wang R; Ding Y; Bai H; Duan S; Ye R; Yang Y; Wang J; Tang R; Gao M; He N
    PLoS One; 2015; 10(7):e0133431. PubMed ID: 26196394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
    Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
    Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study.
    Shiraly R; Jazayeri SA; Seifaei A; Jeihooni AK; Griffiths MD
    Harm Reduct J; 2024 May; 21(1):96. PubMed ID: 38755587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circumstances of initiation into new-type drug use among adults in Shanghai: are there differences by types of first new-type drug used?
    Ding Y; He N; Detels R
    Drug Alcohol Depend; 2013 Aug; 131(3):278-83. PubMed ID: 23312339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis.
    Lewer D; Freer J; King E; Larney S; Degenhardt L; Tweed EJ; Hope VD; Harris M; Millar T; Hayward A; Ciccarone D; Morley KI
    Addiction; 2020 Jun; 115(6):1011-1023. PubMed ID: 31705770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal profile of illicit drug consumption in Guangzhou, China monitored by wastewater-based epidemiology.
    Zhang X; Huang R; Li P; Ren Y; Gao J; Mueller JF; Thai PK
    Environ Sci Pollut Res Int; 2019 Aug; 26(23):23593-23602. PubMed ID: 31203544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, China.
    Dong H; Yang M; Liu L; Zhang C; Liu M; Shen Y; Liu H; Hao W
    BMC Psychiatry; 2017 May; 17(1):183. PubMed ID: 28499448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleeping problems in Chinese illicit drug dependent subjects.
    Tang J; Liao Y; He H; Deng Q; Zhang G; Qi C; Cui H; Jiao B; Yang M; Feng Z; Chen X; Hao W; Liu T
    BMC Psychiatry; 2015 Feb; 15():28. PubMed ID: 25884573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-risk drug use: epidemiological pattern through hair testing in the forensic context].
    Burgueño MJ; Sánchez S; Castro MÁ; Mateos-Campos R
    Rev Esp Salud Publica; 2019 Nov; 93():. PubMed ID: 31767827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a sewage-based approach to assess the use of ten illicit drugs in four Chinese megacities.
    Khan U; van Nuijs AL; Li J; Maho W; Du P; Li K; Hou L; Zhang J; Meng X; Li X; Covaci A
    Sci Total Environ; 2014 Jul; 487():710-21. PubMed ID: 24485909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in and correlates of Australian public attitudes toward illicit drug use.
    Weatherburn D; Alexeev S; Livingston M
    Drug Alcohol Rev; 2022 Jul; 41(5):1029-1040. PubMed ID: 34963035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use.
    Chen YH; Chen MH; Wei HT; Chen LY
    J Formos Med Assoc; 2022 Nov; 121(11):2257-2264. PubMed ID: 35484001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
    Rousis N; Bade R; Romero-Sánchez I; Mueller JF; Thomaidis NS; Thomas KV; Gracia-Lor E
    Environ Int; 2023 Aug; 178():108075. PubMed ID: 37399770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran.
    Nikfarjam A; Shokoohi M; Shahesmaeili A; Haghdoost AA; Baneshi MR; Haji-Maghsoudi S; Rastegari A; Nasehi AA; Memaryan N; Tarjoman T
    Int J Drug Policy; 2016 May; 31():147-52. PubMed ID: 26980349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.